This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
The S&P 500 index fund offers wide exposure to major US companies with low costs. This intro covers benefits and considerations for beginners.
22,658 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Five stalwart Dividend Aristocrats continue to anchor retirement portfolios with rising payouts, steady cash flow, an...
Bitcoin has seen wild swings, but could it really go to zero? This guide breaks down probabilities, failure scenarios...
Kohl's stunned investors with a strong swing in its latest quarterly results, sending the stock higher by double digi...
The chatter around a SpaceX IPO has investors buzzing, but hype can blur fundamentals. This guide breaks down what to...
A major auto parts distributor faced a sharp stock pullback while earnings declined. This guide breaks down what that...
A new stake lift from Bright Valley Capital highlights a high-stakes bet on Vipshop’s rebound. We break down what it ...
uso’s front month strategy has lagged crude across cycles as roll costs erode returns. This piece analyzes why the dr...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...
Peter Thiel's hedge fund sold Nvidia shares and shifted into Microsoft and Apple, signaling a strategic pivot in AI b...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...